Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL)

By  

Cytogenetic and Genome Research, Vol. 118, Iss. 2-4, 2007-11 ,pp. : 353-361

Karger

Access to resources Recommend Favorite

Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 1, 2007-12 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

U.K. national audit of extracorporeal photopheresis in cutaneous T‐cell lymphoma

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 569-570

John Wiley & Sons Inc

Access to resources Recommend Favorite

T‐Cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy

By  

VOX SANGUINIS, Vol. 108, Iss. 1, 2015-01 ,pp. : 82-88

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dramatic efficacy of brentuximab vedotin in two patients with epidermotropic cutaneous T‐cell lymphomas after treatment failure despite variable CD30 expression

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 819-821

John Wiley & Sons Inc

Access to resources Recommend Favorite